| Pharmaceutical active ingredients: |
| Xylometazoline Hydrochloride |
| Available forms, composition and doses of Decongest Nasal: |
| Solution; Nasal; Xylometazoline Hydrochloride 0.1% |
| Decongest Nasal medical category: |
| Human:Nasal decongestants and other nasal preparationsOphthalmic decongestants, anesthetics, anti-inflammatoriesVasoconstrictors |
| Indications and usages, anatomical therapeutic chemical and diseases classification codes: |
| R01AA07 - XylometazolineR01AB06 - XylometazolineS01GA03 - Xylometazoline |
| Pharmaceutical companies: manufacturers, researchers, developers, local distributors and suppliers: |
| Rougier Pharma |
| Trade name |
Active ingredients |
Pharmaceutical company |
|
Decondine | Pseudoephedrine Hydrochloride; Triprolidine Hydrochloride | Sunward Pharmaceutical; Apex Pharma Marketing |
| Deconex 50FF | Didecyl Dimethyl Ammonium Chloride; Glutaraldehyde; Glyoxal | Borer Chemie |
| Deconex 53IN | Alkylamine; Didecyl Dimethyl Ammonium Chloride | Borer Chemie |
| Decongene | Acetaminophen; Caffeine; Phenylpropanolamine Hydrochloride; Pyrilamine Maleate | Stabilimenti Chimico-Farmaceutici Dott. R. Ravasini |
| Decongest | Xylometazoline Hydrochloride | Ratiopharm; Hind Wing |
| Decongestabs | Chlorpheniramine Maleate; Phenylephrine Hydrochloride; Phenylpropanolamine Hydrochloride; Phenyltoloxamine Citrate | Parmed Pharmaceuticals |
| Decongestant | Xylometazoline Hydrochloride | Jamp Pharma |
| Decongestant | Chlorpheniramine Maleate; Phenylephrine Hydrochloride; Phenylpropanolamine Hydrochloride; Phenyltoloxamine Citrate | Moore Medical Corporation |
| Decongestant | Xylometazoline Hydrochloride | Pharmascience |
| Decongestant | Xylometazoline Hydrochloride | Prodemdis |